on 09 Feb 2024
Last Applicant/ Owned by
Osaka-shi Osaka 530-0011
JP
Serial Number
79354840 filed on 24th Jun 2022
Registration Number
N/A
Correspondent Address
Leigh Ann LindquistSUGHRUE MION, PLLC
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research, development and testing of disintegrants for tablets and orally disintegrating tablets using the disintegrants; research, development and testing of rapidly disintegrating tablets and its manufacturing methods; testing of medicines; research and development of medicines; testing, inspection or research of medicines cosmetics or foods; chemical research; testing of chemicals; inspection iRead More
Research, development and testing of disintegrants for tablets and orally disintegrating tablets using the disintegrants; research, development and testing of rapidly disintegrating tablets and its manufacturing methods; testing of medicines; research and development of medicines; testing, inspection or research of medicines cosmetics or foods; chemical research; testing of chemicals; inspection in the field of chemistry for quality control purposes; scientific laboratory services; research and development of new products for others
Medicinal preparations in the form of orally disintegrating tablets for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; oral medicinal preparations in the form of tablets for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; oral medicinal preparations in the form of compressed tablets for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; drug delivery agents in the form of tablets that provide controlled release of the active pharmaceutical ingredients in a wide variety; chemical preparations for medical purposes for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; pharmaceutical preparations for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; pharmaceutical agents for dispensing purposes for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary; pharmaceutical substances for the treatment of cardiovascular, digestive system, central nervous system, respiratory system, hematologic, immunological, metabolic, antibiotic, allergic, oncologic, urologic, musculoskeletal and genetic disease for both human and veterinary
Custom manufacture of pharmaceuticals; custom manufacture of oral medicinal preparations in the form of tablets; custom manufacture of orally disintegrating tablet; providing information relating to custom manufacturing or processing of pharmaceuticals; printing, custom stamping and surface coating of medicinal preparations in the form of tablets; providing information relating to material treatment
No 79354840
No Service Mark
No S26758
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 29th Apr 2024 | NOTIICATION O POSSIBLE OPPOSITION - PROCESSE BY IB |
| 10th Apr 2024 | NOTIICATION O POSSIBLE OPPOSITION CREATE, TO BE SENT TO IB |
| 10th Apr 2024 | NOTIICATION O POSSIBLE OPPOSITION SENT TO IB |
| 09th Feb 2024 | EXTENSION O TIME TO OPPOSE RECEIVE |
| 23rd Jan 2024 | PUBLISHE OR OPPOSITION |
| 23rd Jan 2024 | OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE |
| 22nd Jan 2024 | NOTIICATION PROCESSE BY IB |
| 03rd Jan 2024 | NOTICE O START O OPPOSITION PERIO CREATE, TO BE SENT TO IB |
| 03rd Jan 2024 | NOTIICATION O NOTICE O PUBLICATION E-MAILE |
| 03rd Jan 2024 | NOTIICATION O POSSIBLE OPPOSITION SENT TO IB |
